Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1/2 2Phase 3 1Phase 2 1

Status

Completed 4Terminated 1Active not recruiting 1

Sponsor Class

OTHER 4INDUSTRY 2

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 6

Conditions

Colorectal Neoplasms 21Rectal Neoplasms 10Colonic Neoplasms 6Pancreatic Neoplasms 4Stomach Neoplasms 3Neoplasm Metastasis 3Adenocarcinoma Of Esophagus 3Peritoneal Neoplasms 2Neoplasms 2Liver Neoplasms 2Esophageal Neoplasms 2Pancreatic Adenocarcinoma 1Ovarian Neoplasms 1Neuropathy, Painful 1Neuralgia 1Neoplasm Recurrence, Local 1Malignant Solid Tumour 1Locally Advanced Pancreatic Carcinoma(LAPC) 1Gallbladder Neoplasms 1Esophageal Squamous Cell Carcinoma 1Disease Progression 1Cold Hypersensitivity 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1Carcinoma, Basal Cell 1Breast Neoplasms 1Bile Duct Neoplasms 1Advanced Rectal Cancer 1Advanced Primary Liver Cancer 1Adenocarcinoma of the Lower Rectum 1

Interventions

Leucovorin 38Fluorouracil 36Oxaliplatin 34Bevacizumab 34Irinotecan 32Cetuximab 23Capecitabine 18Panitumumab 14IFL protocol 7Folfox protocol 6Radiotherapy 5Nivolumab 5Magnetic Resonance Spectroscopy 5Immunohistochemistry 5Gene Expression Profiling 5Celecoxib 5regorafenib 4pembrolizumab 4dehydroftorafur 4Ramucirumab 4Fluorodeoxyglucose F18 4Floxuridine 4aflibercept 3Surgical Procedures, Operative 3Sorafenib 3Radiosurgery 3Ipilimumab 3Gemcitabine 3Fentanyl 3Drug Therapy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Has results × Colonic Neoplasms × Folfox protocol × Clear all
NCT04068610 2026-05-15

COLUMBIA-1: Novel Oncology Therapies in Combination With Chemotherapy and Bevacizumab as First- Line Therapy in MSS-CRC

MedImmune LLC

Phase 1/2 Active not recruiting
61 enrolled 35 charts
Gastrointestinal

Colonic Neoplasms

NCT00932438 2021-06-11

DEBIRI

University of Louisville

Phase 1/2 Completed
70 enrolled 10 charts
Gastrointestinal

Colonic Neoplasms

NCT01363843 2020-06-11

Complete Neoadjuvant Treatment for REctal Cancer (CONTRE)

Brown University

Phase 2 Completed
39 enrolled 7 charts
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00265850 2020-05-07

Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Completed
2,334 enrolled 9 charts
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00724503 2019-03-26

SIRFLOX

Sirtex Medical

Phase NA Completed
530 enrolled 14 charts
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT00826800 2015-04-15

Neoadjuvant FOLFOX Plus Bevacizumab Chemotherapy in Patients With Locally Advanced Colon Cancer

Memorial Sloan Kettering Cancer Center

Phase NA Terminated
2 enrolled 4 charts
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡